ENZALUTAMIDE vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ENZALUTAMIDE vs OSIMERTINIB: Safety Overview
| Metric | ENZALUTAMIDE | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 49,270 | 27,750 |
| Deaths Reported | 9,676 | 12,456 |
| Death Rate | 19.6% | 44.9% |
| Hospitalizations | 9,282 | 5,277 |
| Average Patient Age | 76.0 yrs | 68.2 yrs |
| % Female Patients | 0.6% | 66.0% |
| FDA Approval Date | Apr 22, 2022 | Nov 13, 2015 |
| Manufacturer | Astellas Pharma US, Inc. | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |